JW (Cayman) Therapeutics Co. Ltd
JWCTF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $1 | $1 | $5 |
| - Cash | $1 | $1 | $1 | $2 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $3 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -9% | 19.3% | 373.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 48.9% | 50.7% | 40.3% | 29.4% |
| EBITDA | -$0 | -$1 | -$1 | -$1 |
| % Margin | -308.9% | -377.2% | -516.3% | -2,398.6% |
| Net Income | -$1 | -$1 | -$1 | -$1 |
| % Margin | -373.3% | -441.7% | -580.7% | -2,280.5% |
| EPS Diluted | -1.43 | -1.87 | -2.06 | -1.76 |
| % Growth | 23.5% | 9.2% | -17% | – |
| Operating Cash Flow | -$0 | -$0 | -$1 | -$1 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$1 | -$1 |